Jia-Ning Ding

Decreased serum apolipoprotein A1 level predicts poor prognosis of patients with de novo myelodysplastic syndromes

Xiaojiao Zheng, Guifang Ouyang, Ying Chen, 2022, BMC cancer.

Immunotherapy-based therapy as a promising treatment for EGFR-mutant advanced non-small cell lung cancer patients after EGFR-TKI resistance

Jia-Ning Ding, Xinjing Ding, Zhaohui Leng, 2023, Expert review of anticancer therapy.

Differences in pathologic characteristics between ductal carcinoma in situ (DCIS), DCIS with microinvasion and DCIS with invasive ductal carcinoma.

R. Ma, Yinlu Ding, Jianli Wang, 2020, International journal of clinical and experimental pathology.

Etoposide/platinum plus anlotinib for patients with transformed small-cell lung cancer from EGFR-mutant lung adenocarcinoma after EGFR-TKI resistance: a retrospective and observational study

Jia-Ning Ding, Yun Song, Xiangjing Jing, 2023, Frontiers in Oncology.

Histological transformation into SCLC: An important resistance mechanism of NSCLC upon immunotherapy

Jia-Ning Ding, Xinjing Ding, Jiao Zeng, 2023, Frontiers in immunology.

Red blood cell-derived materials for cancer therapy: Construction, distribution, and applications

Jia-Ning Ding, Xinjing Ding, Zhihui Lu, 2023, Materials today. Bio.